Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRISP: Corticosteroids in Severe Pancreatitis
NCT05160506Phase 2Recruiting
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Mar 2022
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydrocortisone in acute pancreatitis (AP), sponsored by Beth Israel Deaconess Medical Center. Started Mar 2022; status: recruiting.
02
Drugs
hydrocortisone
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT05160506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05160506.